Latest filing published 01 Aug 2017 for Oasmia Pharmaceutical AB, €1,194.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mikael Asp: trading record in brief
Mikael Asp discloses dealings in Oasmia Pharmaceutical AB to Finansinspektionen. In total, 3 filings cover trades dated from 5 December 2016 to 1 August 2017.
On the market, this insider has only ever bought: 3 purchases, €8,770 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2017 alone, the filings show 2 purchases and no sales.
The median purchase comes to €3,781. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
On 1 August 2017 came the latest disclosure, an open-market purchase for €1,194 in Oasmia Pharmaceutical AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mikael Asp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,520 shares@ SEK 3.2523.9% of flowISIN SE0010101188FI:csv-e6a567614f19c4b647caCanonical exit: 30 Oct 2017 (T+90)
- 168,182 shares@ SEK 0.2276.1% of flowISIN SE0000722365FI:csv-891eb3aed3810256d787Canonical exit: 17 Sept 2017 (T+90)
- 100,000 shares@ SEK 0.37100.0% of flowFI:csv-d23ede55a3dc3a07c9a6Canonical exit: 5 Mar 2017 (T+90)
3 of 3 declarations